The effect of a tightly bound water molecule on scaffold diversity in the computer-aided de novo ligand design of CDK2 inhibitors

被引:31
作者
García-Sosa, AT
Mancera, RL
机构
[1] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England
[2] Curtin Univ Technol, Western Australia Biomed Res Inst, Sch Biomed Sci, Perth, WA 6865, Australia
[3] Curtin Univ Technol, Western Australia Biomed Res Inst, Sch Pharm, Perth, WA 6865, Australia
[4] Mayo Clin Coll Med, Comp Aided Mol Design Lab, Rochester, MN 55905 USA
关键词
hydration; solvation; structure-based drug design; CDK2;
D O I
10.1007/s00894-005-0063-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have determined the effects that tightly bound water molecules have on the de novo design of cyclin-dependent kinase-2 (CDK2) ligands. In particular, we have analyzed the impact of a specific structural water molecule on the chemical diversity and binding mode of ligands generated through a de novo structure-based ligand generation method in the binding site of CDK2. The tightly bound water molecule modifies the size and shape of the binding site and we have found that it also imposed constraints on the observed binding modes of the generated ligands. This in turn had the indirect effect of reducing the chemical diversity of the underlying molecular scaffolds that were able to bind to the enzyme satisfactorily.
引用
收藏
页码:422 / 431
页数:10
相关论文
共 46 条
[1]   Imidazo[1,2-a]pyridines:: A potent and selective class of cyclin-dependent kinase inhibitors identified through structure-based hybridisation [J].
Anderson, M ;
Beattie, JF ;
Breault, GA ;
Breed, J ;
Byth, KF ;
Culshaw, JD ;
Ellston, RPA ;
Green, S ;
Minshull, CA ;
Norman, RA ;
Pauptit, RA ;
Stanway, J ;
Thomas, AP ;
Jewsbury, PJ .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (18) :3021-3026
[2]   Cyclin-dependent kinase 4 inhibitors as a treatment for cancer. Part 1: Identification and optimisation of substituted 4,6-bis anilino pyrimidines [J].
Beattie, JF ;
Breault, GA ;
Ellston, RPA ;
Green, S ;
Jewsbury, PJ ;
Midgley, CJ ;
Naven, RT ;
Minshull, CA ;
Pauptit, RA ;
Tucker, JA ;
Pease, JE .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (18) :2955-2960
[3]   The Protein Data Bank [J].
Berman, HM ;
Westbrook, J ;
Feng, Z ;
Gilliland, G ;
Bhat, TN ;
Weissig, H ;
Shindyalov, IN ;
Bourne, PE .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :235-242
[4]   Cyclin-dependent kinase 4 inhibitors as a treatment for cancer. Part 2: Identification and optimisation of substituted 2,4-bis anilino pyrimidines [J].
Breault, GA ;
Ellston, RPA ;
Green, S ;
James, SR ;
Jewsbury, PJ ;
Midgley, CJ ;
Pauptit, RA ;
Minshull, CA ;
Tucker, JA ;
Pease, JE .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (18) :2961-2966
[5]   Structure-based design of potent inhibitors of scytalone dehydratase: Displacement of a water molecule from the active site [J].
Chen, JM ;
Xu, SL ;
Wawrzak, Z ;
Basarab, GS ;
Jordan, DB .
BIOCHEMISTRY, 1998, 37 (51) :17735-17744
[6]   Active site water molecules revealed in the 2.1 Å resolution structure of a site-directed mutant of isocitrate dehydrogenase [J].
Cherbavaz, DB ;
Lee, ME ;
Stroud, RM ;
Koshland, DE .
JOURNAL OF MOLECULAR BIOLOGY, 2000, 295 (03) :377-385
[7]   Mass spectrometric and thermodynamic studies reveal the role of water molecules in complexes formed between SH2 domains and tyrosyl phosphopeptides [J].
Chung, E ;
Henriques, D ;
Renzoni, D ;
Zvelebil, M ;
Bradshaw, JM ;
Waksman, G ;
Robinson, CV ;
Ladbury, JE .
STRUCTURE, 1998, 6 (09) :1141-1151
[8]   Structure-based design of cyclin-dependent kinase inhibitors [J].
Davies, TG ;
Pratt, DJ ;
Endicott, JA ;
Johnson, LN ;
Noble, MEM .
PHARMACOLOGY & THERAPEUTICS, 2002, 93 (2-3) :125-133
[9]   Application and limitations of X-ray crystallographic data in structure-based ligand and drug design [J].
Davis, AM ;
Teague, SJ ;
Kleywegt, GJ .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2003, 42 (24) :2718-2736
[10]  
DE AWJ, 1996, P NATL ACAD SCI USA, V93, P2735